News On FSD Pharma Inc. (HUGE) Now Under QNTM
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"
FSD Pharma Inc To Carry Out 1-for-65 Reverse Stock Split On August 15th, 2024
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma
24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
FSD Pharma Edging Up In US Premarket Trade As Signs Agreement With INGENu CRO
FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus
FSD Pharma Inc. Announces Closing of Private Placement
Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc.
FSD Pharma Says Arbitration Panel Finds That Nasdaq-listed Syneos Health "Failed to Use Commercially Reasonable Efforts in Conducting Its Trial for FSD 201"
FSD Pharma Inc. (NASDAQ:HUGE) Short Interest Up 26.4% in April
FSD Pharma Inc. (NASDAQ:HUGE) Short Interest Up 6.5% in March
FSD Pharma Inc. Class B Shares To Resume Trade At 9:00 A.m. ET
FSD Pharma Inc. (NASDAQ:HUGE) Short Interest Update
FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia
FSD Pharma Inc. (NASDAQ:HUGE) Short Interest Up 15.9% in August
FSD Pharma Inc. (NASDAQ:HUGE) Sees Large Growth in Short Interest
FSD Pharma Inc. Announces Results of Annual General Meeting of Shareholders And Other Corporate Updates
Insider Buying: FSD Pharma Inc (CNSX:HUGE) Director Acquires 50,000 Shares of Stock
No Data